The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.

about

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

P2860

Q34550471-9772E88B-EF32-4BEF-AC77-AC392F433573 Q47984024-BE57D176-0358-4385-8D36-D18899831D86

P2860

The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.

Item

http://www.wikidata.org/entity/Q38478483

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Effectiveness of Anti-leuk ...... emic Review and Meta-analysis.

@en

type

Item

label

The Effectiveness of Anti-leuk ...... emic Review and Meta-analysis.

@en

prefLabel

The Effectiveness of Anti-leuk ...... emic Review and Meta-analysis.

@en

P1476

The Effectiveness of Anti-leuk ...... emic Review and Meta-analysis.

@en

P2093

Hyun Jung Kim

http://www.w3.org/2001/XMLSchema#string

Jong Hoo Lee

http://www.w3.org/2001/XMLSchema#string

Yee Hyung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory biomarkers in sputum predict COPD exacerbations.

Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

Exhaled leukotrienes and prostaglandins in COPD.

Antileukotriene drugs: clinical application, effectiveness and safety.

Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.

Targeting leukotrienes for the treatment of COPD?

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Long-acting anticholinergic agents in patients with uncontrolled asthma: a systematic review and meta-analysis.

A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD.

P2888

s00408-015-9743-5

P304

477-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00408-015-9743-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027009693

http://www.w3.org/2001/XMLSchema#string

P698

25972156

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.

about

P2860

P2860

The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921